AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9797854 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone (OX)
Number of subjects: 32
Study 9797854 — intervention group
Group type: COMPARATOR
Intervention: Normal girls (control group)
Number of subjects: 32
Study 8130811 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (offering food based on need expressions and vegetable acceptance)
Number of subjects: 132
Study 8130811 — intervention group
Group type: COMPARATOR
Intervention: Control group (maintained higher energy intake)
Number of subjects: 132
Study 2492424 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation (hypocapnia) during extinction phase
Number of subjects: 0
Study 2492424 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hyperventilation)
Number of subjects: 0
Study 31074821 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative phase 3 RCTs with a phase 2 trial available
Number of subjects: 64600
Study 31074821 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative phase 3 RCTs with a hazard ratio above 1.00
Number of subjects: 64600
Study 27322159 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-weekly peer play psychotherapy (PPP)
Number of subjects: 47
Study 27322159 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dosage of PPP
Number of subjects: 47
Study 27322159 — intervention group
Group type: COMPARATOR
Intervention: Non-playgroup (NPG) children
Number of subjects: 47
Study 25872588 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured exercise training program (8-week outpatient program, combining endurance and resistance training, 3 sessions per week)
Number of subjects: 96
Study 25872588 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured exercise training program
Number of subjects: 96
Study 25872588 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 96
Study 23855816 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl buccal tablet
Number of subjects: 213
Study 23855816 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release oxycodone
Number of subjects: 213
Study 21324954 — intervention group
Group type: EXPERIMENTAL
Intervention: World Health Organisation performance status (PS)
Number of subjects: 0
Study 21324954 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-mental state examination (MMSE)
Number of subjects: 0
Study 19035972 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 6 mg/day
Number of subjects: 417
Study 19035972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 417
Study 17028986 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone mineral density (BMD)
Number of subjects: 2576
Study 17028986 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 2576
Study 17028986 — intervention group
Group type: EXPERIMENTAL
Intervention: Family history of breast cancer
Number of subjects: 2576
Study 17028986 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol level
Number of subjects: 2576
Study 17028986 — intervention group
Group type: EXPERIMENTAL
Intervention: Femoral neck BMD
Number of subjects: 2576
Study 17028986 — intervention group
Group type: EXPERIMENTAL
Intervention: BMD and estradiol interaction
Number of subjects: 2576
Study 15454247 — intervention group
Group type: EXPERIMENTAL
Intervention: Infused 5-fluorouracil (5FU) +/- mitomycin-C (MMC) for patients with oesophagogastric cancer who could not tolerate cis-platinum-containing regimens
Number of subjects: 1720
Study 15454247 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy for advanced disease
Number of subjects: 1720
Study 15454247 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy for colorectal cancer
Number of subjects: 1720
Study 15648465 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 hours time in bed
Number of subjects: 26
Study 15648465 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 hours time in bed
Number of subjects: 26
Study 15648465 — intervention group
Group type: COMPARATOR
Intervention: 8.5 hours time in bed (control group)
Number of subjects: 26
Study 11296075 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Steps for Young Children Program (HS)
Number of subjects: 4896
Study 9030806 — intervention group
Group type: EXPERIMENTAL
Intervention: Normothermic CPB (warm group)
Number of subjects: 40
Study 9030806 — intervention group
Group type: COMPARATOR
Intervention: Hypothermic CPB (cold group)
Number of subjects: 40
Study 8339807 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled frusemide (40 mg)
Number of subjects: 19
Study 8339807 — intervention group
Group type: COMPARATOR
Intervention: 0.15 M NaCl control
Number of subjects: 19
Study 3807448 — intervention group
Group type: EXPERIMENTAL
Intervention: Group practices
Number of subjects: 0
Study 3807448 — intervention group
Group type: COMPARATOR
Intervention: Traditional clinics
Number of subjects: 0
Study 31778647 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthocran®
Number of subjects: 0
Study 31778647 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthocran™ Phytosome™
Number of subjects: 0
Study 31778647 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure standards mimicking urinary fraction at 12 h
Number of subjects: 0
Study 29358119 — intervention group
Group type: EXPERIMENTAL
Intervention: Low subjective socioeconomic status (SSS)
Number of subjects: 48
Study 29358119 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 48
Study 27343685 — intervention group
Group type: EXPERIMENTAL
Intervention: high-frequency transcranial random noise stimulation (hf-tRNS) with perceptual learning training (8 sessions)
Number of subjects: 0
Study 27343685 — intervention group
Group type: COMPARATOR
Intervention: sham stimulation with perceptual learning training (8 sessions)
Number of subjects: 0
Study 27343685 — intervention group
Group type: COMPARATOR
Intervention: hf-tRNS with no concurrent training
Number of subjects: 0
Study 24636027 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine soaks 3 times daily
Number of subjects: 100
Study 24636027 — intervention group
Group type: COMPARATOR
Intervention: Daily dressing changes
Number of subjects: 100
Study 24294874 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased alertness
Number of subjects: 0
Study 24294874 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive control
Number of subjects: 0
Study 24294874 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation results
Number of subjects: 0
Study 20048204 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 40 mg daily
Number of subjects: 269
Study 20048204 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study 18175337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 484
Study 18175337 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarizotan (2 mg/day)
Number of subjects: 484
Study 16620167 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention group (V) - traditional skilled nursing care at home and virtual visits using videoconferencing technology.
Number of subjects: 0
Study 16620167 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring intervention group (M) - traditional skilled nursing care at home, virtual visits using videoconferencing technology, and physiologic monitoring.
Number of subjects: 0
Study 16620167 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) - traditional skilled nursing care at home.
Number of subjects: 0
Study 16620167 — intervention group
Group type: EXPERIMENTAL
Intervention: Video intervention group (V) and Monitoring intervention group (M) - evaluated by changes in the knowledge, behavior and status scales of the Omaha Assessment Tool.
Number of subjects: 0
Study 16620167 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face home visits (C)
Number of subjects: 0
Study 16620167 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual visits (video group) (V)
Number of subjects: 0
Study 16620167 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring group visits for congestive heart failure (M)
Number of subjects: 0
Study 16620167 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring group visits for chronic obstructive pulmonary disease (M)
Number of subjects: 0
Study 12889719 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapalene gel 0.1%
Number of subjects: 42
Study 12889719 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapalene solution 0.1%
Number of subjects: 42
Study 12889719 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene gel 0.1%
Number of subjects: 42
Study 12889719 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene gel 0.05%
Number of subjects: 42
Study 12889719 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin microsphere gel 0.1%
Number of subjects: 42
Study 12889719 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin cream 0.025%
Number of subjects: 42
Study 12889719 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin gel 0.025%
Number of subjects: 42
Study 12889719 — intervention group
Group type: COMPARATOR
Intervention: White petrolatum (negative control)
Number of subjects: 42
Study 10392868 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine 0.4 mg
Number of subjects: 32
Study 10392868 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine 0.6 mg
Number of subjects: 32
Study 10392868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 8896124 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid 500 mg/6 h
Number of subjects: 0
Study 8896124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12317784 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin phosphate vaginal cream 2%, 5 grams intravaginally at bedtime
Number of subjects: 184
Study 12317784 — intervention group
Group type: COMPARATOR
Intervention: Oral metronidazole capsules, 500 mg, taken twice daily
Number of subjects: 184
Study 6524903 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoperazone
Number of subjects: 27
Study 6524903 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoperazone plus amikacin
Number of subjects: 27
Study 31633778 — intervention group
Group type: EXPERIMENTAL
Intervention: BF/EF group (breastfeeding with amino acid-based elemental formula for at least the first 3 days of life)
Number of subjects: 312
Study 31633778 — intervention group
Group type: COMPARATOR
Intervention: BF plus CMF group (breastfeeding supplemented with cow's milk formula ≥5 mL/d from the first day of life to 5 months of age)
Number of subjects: 312
Study 31633778 — intervention group
Group type: EXPERIMENTAL
Intervention: BF/EF group
Number of subjects: 312
Study 31633778 — intervention group
Group type: COMPARATOR
Intervention: BF plus CMF group
Number of subjects: 312
Study 28082337 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body positive pressure (LBPP, 10‐30 min)
Number of subjects: 15
Study 28082337 — intervention group
Group type: COMPARATOR
Intervention: Control (no LBPP)
Number of subjects: 15
Study 25923487 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D and calcium-fortified yogurts (FY)
Number of subjects: 48
Study 25923487 — intervention group
Group type: COMPARATOR
Intervention: Non-fortified control yogurts (CY)
Number of subjects: 48
Study 23968340 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-oriented self-management educational program
Number of subjects: 540
Study 23968340 — intervention group
Group type: COMPARATOR
Intervention: Usual care educational program (short lecture-based)
Number of subjects: 540
Study 21470388 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy Silicone Oil (HSO)
Number of subjects: 93
Study 21470388 — intervention group
Group type: COMPARATOR
Intervention: Standard Silicone Oil
Number of subjects: 93
Study 19735103 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid decompression
Number of subjects: 28
Study 19735103 — intervention group
Group type: COMPARATOR
Intervention: Two-level corpectomy
Number of subjects: 28
Study 18693605 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation for six months
Number of subjects: 0
Study 15473497 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life (QL) assessment at five timepoints
Number of subjects: 186
Study 15473497 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent QL estimates
Number of subjects: 186
Study 15473497 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation process in early colon cancer patients
Number of subjects: 186
Study 12441903 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal training in CVC insertion and care
Number of subjects: 0
Study 12441903 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of maximal sterile barriers at insertion
Number of subjects: 0
Study 12441903 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of chlorhexidine rather than povidone-iodine for cutaneous antisepsis
Number of subjects: 0
Study 12441903 — intervention group
Group type: EXPERIMENTAL
Intervention: Applying a topical anti-infective cream or ointment or a chlorhexidine-impregnated dressing to the insertion site
Number of subjects: 0
Study 12441903 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of novel catheters with an anti-infective surface or a contamination-resistant hub
Number of subjects: 0
Study 9391222 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release nifedipine 30 mg orally
Number of subjects: 17
Study 9391222 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 7882281 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy and irradiation
Number of subjects: 573
Study 7882281 — intervention group
Group type: COMPARATOR
Intervention: Lumpectomy alone
Number of subjects: 573
Study 2296931 — intervention group
Group type: EXPERIMENTAL
Intervention: Single, oral high dose of vitamin A (n = 65)
Number of subjects: 134
Study 2296931 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 69)
Number of subjects: 134
Study 354041 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbuterol 200 microgram
Number of subjects: 10
Study 354041 — intervention group
Group type: COMPARATOR
Intervention: Hexoprenaline 200 microgram
Number of subjects: 10
Study 354041 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 7043710 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin sustained-release 75 mg capsule b.i.d.
Number of subjects: 86
Study 7043710 — intervention group
Group type: COMPARATOR
Intervention: Conventional indomethacin 50 mg capsule t.i.d.
Number of subjects: 86
Study 7043710 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 86
Study 31412029 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) using Samsung Gear Oculus headset; 21 VR experiences.
Number of subjects: 120
Study 31412029 — intervention group
Group type: COMPARATOR
Intervention: Control group viewing specialized health and wellness television programming.
Number of subjects: 120
Study 29543933 — intervention group
Group type: EXPERIMENTAL
Intervention: 79.2 Gy radiation therapy
Number of subjects: 1532
Study 29543933 — intervention group
Group type: COMPARATOR
Intervention: 70.2 Gy radiation therapy
Number of subjects: 1532
Study 26135754 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 25 mg IV for the first week, decreasing to 12.5 mg during the 2nd week until birth
Number of subjects: 48
Study 26135754 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) matching IV treatment
Number of subjects: 48
Study 26135754 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 48
Study 25288473 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin-releasing hormone antagonist (GnRH-ant)
Number of subjects: 50
Study 25288473 — intervention group
Group type: COMPARATOR
Intervention: Gonadotropin-releasing hormone agonist (GnRH-a)
Number of subjects: 50
Study 22712670 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol + Sufentanil (group SF)
Number of subjects: 46
Study 22712670 — intervention group
Group type: COMPARATOR
Intervention: Propofol + Remifentanil (group RF)
Number of subjects: 46
Study 19859806 — intervention group
Group type: EXPERIMENTAL
Intervention: All Stars prevention curriculum
Number of subjects: 447
Study 19859806 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dosage of All Stars
Number of subjects: 447
Study 19859806 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher quality program delivery of All Stars
Number of subjects: 447
Study 19859806 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of higher dosage and higher quality delivery of All Stars
Number of subjects: 447
Study 19859806 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 447
Study 17921403 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (400 microg/d)
Number of subjects: 130
Study 17921403 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 15550992 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment (Protopic)
Number of subjects: 0
Study 11748093 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg subcutaneous injection)
Number of subjects: 13
Study 11748093 — intervention group
Group type: COMPARATOR
Intervention: Control group (no etanercept)
Number of subjects: 13
Study 9291905 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 50
Study 9291905 — intervention group
Group type: COMPARATOR
Intervention: Mechanical antipyresis alone
Number of subjects: 50
Study 8332271 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone (Group C: 0.5 mg/kg bolus and slow infusion at 10 gamma/kg/min)
Number of subjects: 20
Study 8332271 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone (all groups)
Number of subjects: 20
Study 8332271 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone
Number of subjects: 20
Study 2437095 — intervention group
Group type: COMPARATOR
Intervention: Acyclovir alone for five days
Number of subjects: 31
Study 2437095 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir for five days and isoprinosine for ten days
Number of subjects: 31
Study 2437095 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir for five days and levamisole twice weekly for three weeks
Number of subjects: 31
Study 28965344 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Exercise (HI - 80% of 1RM)
Number of subjects: 10
Study 28965344 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Intensity Exercise with Blood Flow Restriction (LI-BFR - 20% of 1RM, 160 mmHg of BFR)
Number of subjects: 10
Study 28965344 — intervention group
Group type: COMPARATOR
Intervention: Control (CON - no exercise or BFR)
Number of subjects: 10
Study 25725192 — intervention group
Group type: EXPERIMENTAL
Intervention: Designed sport
Number of subjects: 0
Study 25725192 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 0
Study 25725192 — intervention group
Group type: COMPARATOR
Intervention: Working memory training
Number of subjects: 0
Study 24813561 — intervention group
Group type: EXPERIMENTAL
Intervention: Macitentan 10 mg
Number of subjects: 64
Study 24813561 — intervention group
Group type: EXPERIMENTAL
Intervention: Macitentan 30 mg
Number of subjects: 64
Study 24813561 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 24813561 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Number of subjects: 64
Study 22274809 — intervention group
Group type: EXPERIMENTAL
Intervention: Once daily gonadotropin administration
Number of subjects: 213
Study 19358785 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation of the same medications after acute treatment (mood stabilizer plus antidepressant) for 1 year
Number of subjects: 83
Study 17469939 — intervention group
Group type: EXPERIMENTAL
Intervention: High-yield nicotine cigarette
Number of subjects: 0
Study 17469939 — intervention group
Group type: COMPARATOR
Intervention: Placebo (denicotinized cigarette)
Number of subjects: 0
Study 15870414 — intervention group
Group type: EXPERIMENTAL
Intervention: Single high-dose bolus tirofiban plus sirolimus-eluting stenting (n = 87)
Number of subjects: 175
Study 15870414 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose abciximab plus bare-metal stenting (n = 88)
Number of subjects: 175
Study 15870414 — intervention group
Group type: EXPERIMENTAL
Intervention: Single high-dose bolus tirofiban plus sirolimus-eluting stenting
Number of subjects: 175
Study 15870414 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose abciximab plus bare-metal stenting
Number of subjects: 175
Study 11430966 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 1004
Study 9927831 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (0.15 mg/kg intravenous dose followed by infusion of 3 micrograms/kg/min for 3 hours)
Number of subjects: 60
Study 9927831 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equivalent amount to diltiazem)
Number of subjects: 60
Study 9927831 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 60
Study 9927831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 7919299 — intervention group
Group type: EXPERIMENTAL
Intervention: New esthesiometer used for diagnosis of hand-arm vibration syndrome
Number of subjects: 34
Study 7919299 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 34
Study 3281001 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravariceal sclerotherapy
Number of subjects: 95
Study 3281001 — intervention group
Group type: COMPARATOR
Intervention: Control group (no sclerotherapy)
Number of subjects: 95
Study 31116189 — intervention group
Group type: EXPERIMENTAL
Intervention: Suturing plus advanced‐platelet‐rich fibrin (A‐PRF+) plug
Number of subjects: 40
Study 31116189 — intervention group
Group type: COMPARATOR
Intervention: Suturing alone (control group)
Number of subjects: 40
Study 31116189 — intervention group
Group type: EXPERIMENTAL
Intervention: Suturing plus haemostatic plug (HAEM)
Number of subjects: 40
Study 31116189 — intervention group
Group type: EXPERIMENTAL
Intervention: Suturing plus leukocyte- and platelet-rich fibrin (L-PRF) plug
Number of subjects: 40
Study 28720230 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 50
Study 28720230 — intervention group
Group type: COMPARATOR
Intervention: Sham (touching points within 1cm of main points)
Number of subjects: 50